Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanofi (GB:0O59)
LSE:0O59
Holding GB:0O59?
Track your performance easily
See the Price Targets and Ratings of:
0O59 Analyst Ratings
Moderate Buy
9 Buy
3 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0O59 Stock 12 Month Forecast
Average Price Target
€112.34
▲(17.21% Upside)
| Highest Price Target€130.00 | Average Price Target€112.34 | Lowest Price Target€90.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Deutsche Bank
Reiterated
10/28/24
DZ BANK AG
Reiterated
10/28/24
Leerink Partners
Reiterated
10/27/24
J.P. Morgan
Reiterated
10/25/24
Bank of America Securities
Reiterated
10/25/24
Kepler Capital
Reiterated
10/25/24
Jefferies
Assigned
10/22/24
Berenberg Bank
Reiterated
10/18/24
Bernstein
Reiterated
10/11/24
Stifel Nicolaus
€111→€123
Buy
28.34%
Upside
Reiterated
09/24/24
Sanofi's Promising Portfolio Drives Buy Rating Amid MS, Cancer Breakthroughs, and Vaccine Expansion
Barclays
€105→€120
Buy
25.21%
Upside
Reiterated
09/23/24
Sanofi (SNYNF) Receives a Buy from Barclays
Citi
€125→€130
Buy
35.65%
Upside
Reiterated
09/16/24
Sanofi (SAN:FP) (SNY) PT Raised to EUR130 at Citi, sees 'a highly attractive risk-reward'Citi analyst Peter Verdult raised the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR130.00 (from EUR125.00) while maintaining a Buy rating.
Guggenheim
€118→€125
Buy
30.43%
Upside
Reiterated
07/11/24
Sanofi price target raised to EUR 125 from EUR 118 at GuggenheimSanofi price target raised to EUR 125 from EUR 118 at Guggenheim
Morgan Stanley
€51.65
Hold
-46.11%
Downside
Reiterated
01/23/24
Morgan Stanley starts Sanofi-Aventis (SNY) at EqualweightMorgan Stanley analyst Mark Purcell initiates coverage on Sanofi-Aventis (NASDAQ: SNY) with a Equalweight rating and a price target of $55.00.
Best Analysts Covering Sanofi
Which Analyst Should I Follow If I Want to Buy GB:0O59 and Sell After:
1 Month
xxx
Success Rate
12/20 ratings generated profit
Average Return
+1.02%
reiterated a xxx
rating 19 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +1.02% per trade.
3 Months
xxx
Success Rate
24/38 ratings generated profit
Average Return
+2.32%
assigned a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 63.16% of your transactions generating a profit, with an average return of +2.32% per trade.
1 Year
Success Rate
27/38 ratings generated profit
Average Return
+4.96%
assigned a buy rating 22 days ago
Copying Peter Welford's trades and holding each position for 1 Year would result in 71.05% of your transactions generating a profit, with an average return of +4.96% per trade.
2 Years
xxx
Success Rate
28/38 ratings generated profit
Average Return
+8.15%
assigned a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 73.68% of your transactions generating a profit, with an average return of +8.15% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0O59 Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Sep 24
Oct 24
Strong Buy
0
0
0
0
0
Buy
20
22
17
25
23
Hold
7
9
10
10
10
Sell
3
4
4
5
6
Strong Sell
0
0
0
0
0
total
30
35
31
40
39
Each month's total comprises the sum of three months' worth of ratings.
0O59 Financial Forecast
0O59 Stock Forecast FAQ
What is GB:0O59’s average 12-month price target, according to analysts?
Based on analyst ratings, Sanofi’s 12-month average price target is €112.34.
What is GB:0O59’s upside potential, based on the analysts’ average price target?
Sanofi has 17.21% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sanofi a Buy, Sell or Hold?
Sanofi has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 3 hold ratings and 1 sell ratings.
What is Sanofi’s share price target?
The average share price target for Sanofi is €112.34. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €130.00 ,and the lowest forecast is €90.00. The average share price target represents 17.21% Increase from the current price of €95.838.
The highest analyst share price target is €130.00 ,and the lowest forecast is €90.00. The average share price target represents 17.21% Increase from the current price of €95.838.
What do analysts say about Sanofi?
Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of Sanofi?
To buy shares of GB:0O59, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.